Skip to content

Drug interactions

Bosentan + Pomalidomide

Severity: Minor

Bosentan and Pomalidomide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pomalidomide is partly metabolized by CYP3A4, but also by CYP1A2 and other routes. A CYP3A4 inducer is unlikely to change its exposure much, though both drugs are teratogenic and require strict pregnancy-prevention programs.

What this interaction means in plain words

Bosentan and Pomalidomide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Bosentan belongs to Miscellaneous; Pomalidomide belongs to Miscellaneous.

Evidence level: Low

Why it happens

Bosentan may modestly increase CYP3A4-mediated pomalidomide metabolism, which is a minor clearance pathway.

What to do

No dose change is generally needed. Ensure both pregnancy-prevention programs are followed and monitor response.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Pomalidomide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosentan with Pomalidomide?

MediHelp rates the interaction as minor. Bosentan and Pomalidomide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Pomalidomide is partly metabolized by CYP3A4, but also by CYP1A2 and other routes. A CYP3A4 inducer is unlikely to change its exposure much, though both drugs are teratogenic and require strict pregnancy-prevention programs.

How serious is the interaction between Bosentan and Pomalidomide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is generally needed. Ensure both pregnancy-prevention programs are followed and monitor response.

What other medicines interact with Bosentan?

MediHelp also lists interactions of Bosentan with, for example, Cyclosporin, Glibenclamide, Glyburide-metformin. The full list is on the Bosentan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in